A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...